Department of Epidemiology and Biostatistics, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, California, USA.
Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA.
Pediatr Blood Cancer. 2024 Dec;71(12):e31328. doi: 10.1002/pbc.31328. Epub 2024 Sep 17.
Lifelong, guideline-based monitoring for late effects is recommended for childhood cancer survivors (CCS). We examined rates of receiving surveillance tests among at-risk young adult CCS in a population-based study (n = 253; 50% Hispanic/Latino; mean post-treatment interval 14.5 years, range: 5-22). Adherence rates were 36.1%, 31.9%, and 36.4% among those indicated for cardiac (n = 119), thyroid (n = 68), and breast (n = 66) surveillance, respectively, indicating that poor surveillance among long-term CCS is widespread. Receipt of any of these surveillance tests was positively associated with being in follow-up care, having any health insurance (vs. none), and receiving education about need for follow-up with surveillance (all p-values less than .05).
建议对儿童癌症幸存者（CCS）进行终生、基于指南的晚期效应监测。我们在一项基于人群的研究中（n=253；50%为西班牙裔/拉丁裔；治疗后平均间隔 14.5 年，范围：5-22），检查了高危年轻成年 CCS 接受监测测试的比率。分别有 36.1%、31.9%和 36.4%的患者接受了心脏（n=119）、甲状腺（n=68）和乳腺（n=66）监测，表明长期 CCS 的监测不佳是普遍存在的。接受这些监测测试中的任何一项均与接受随访护理、拥有任何医疗保险（而非没有）以及接受有关需要进行随访监测的教育有关（所有 p 值均小于.05）。
